IndiaTickerShukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday, July 14, 2026 For Confirmation Of Receipt Of The Differential Upfront Consideration From The Allottees Pursuant To Regulation 170(2) Of The SEBI (ICDR) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Shukra Pharmaceuticals
BSE:SHUKRAPHAR · ISIN INE551C01044
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Shukra Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Shukra Pharmaceuticals Ltd - 524632 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - EGM Voting ResultsBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Appointment And Resignation Of Company Secretary & Compliance OfficerBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Notice Of EGM To Be Held On 6Th July 2026BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Wednesday, June 10, 2026BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Ratification Of Approval For Member''s Resolution Passed In The Extra-Ordinary General Meeting Dated 01St November, 2025BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome For The Board Meeting Dated 07.05.2026 For The Audited Financial Results For The Quarter And Year Ended March, 2026BSE · financial results · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Results For The Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-AllotmentBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Regulation 32 For Starement Of DeviationBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March, 2026 Along With The Auditor''s ReportBSE · financial results · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Independent Directors MeetingBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Independent Directors MeetingBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Newspaper Publication Of Standalone And Consolidated Un-Audited Financial Results For Quarter And Nine Month Ended 31St December 2025BSE · financial results · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Unaudited Financial Results For The Quarter Ended December 2025BSE · financial results · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday, February 04, 2026BSE · financial results · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Update on board meetingBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31 December, 2025 Along With The Auditor''s Limited Review Report.BSE · financial results · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On TodayBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-AllotmentBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Voting Result Along With Scrutinizer Report Of Postal BallotBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Reconstitution Of Committees Of The Company.BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On December 30, 2025.BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Intimation For Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations, Working In The Government Market Of Gujarat For Our Laparoscopic Sets And Accessories.BSE · exchange filing · pdf
Source filing Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing